The Protein Labelling Market size in the Asia Pacific was valued at USD 0.29 billion in 2021. It is further estimated to grow at a CAGR of 14.52% and value USD 0.56 billion by 2026.
Protein labeling is done using labeling reagents and kits to label an antibody or other protein, to make an enzyme conjugate, fluorescent probe, biotinylated binding reagent iodine-labeled tracer for detecting proteins in tissues, cells, and biochemical assays.
Protein labeling methods include in-Vivo and in-Vitro labeling techniques. These techniques are based on genetic engineering, which provides for improved high sensitivity and imaging technology. Snap-tag and halo-tag are widely used technology in in-vivo and in-vitro labeling. Halo-tag and snap-tag are significant tools for functional protein analysis to form a covalent bond between protein fusion tag and synthetic chemical ligand. These tools enable us to profoundly explore proteomics and genomics with high affinity and specificity to determine disease state.
Improved healthcare spending and healthcare expenditure, rising R&D spending, increasing proteomics research, infrastructure development, favorable government policies, Cell culture-based experiments, rise in adoption of personalized medicines, and the growth of flow Cytometry tissue diagnostics are expected to create significant demand for Asia Pacific protein labeling. Also, growing proteomics research is bolstering market growth.
However, lack of skilled professionals, lack of awareness, and high costs of products hinder the market growth.
This research report on the Asia Pacific Protein Labelling Market has been segmented and sub-segmented into the following categories:
By Product:
By Labelling:
By Application:
By Country:
Based on the region, the Asia Pacific is expected to be the fastest-growing segment with a global share of 16% and has a CAGR of 14.52% due to the increased demands of emerging economies such as Japan and China, growing demographics, and rise in healthcare expenditure. As a result, the Asia Pacific market is one of the fastest-growing markets globally for protein labeling. The regional market growth is driven owing to the increasing research and development activities in recent years. Also, the increase in proteomics research is boosting the market growth of the protein labeling market.
China expanding economy is experiencing the highest growth rate in recent years. The increased spending on healthcare and research and development activities contributes to the Chinese protein labeling market growth.
Similarly, India and Japan are also growing significantly due to the increasing research and development, which has reduced the complexity of protein labeling procedures. In addition, the government policies are also favorable for the growth of the market in these regions.
On the other hand, Australia, Malaysia, and Singapore are some countries that can see significant growth in the coming years due to the shifting focus of substantial players from developed markets to developing markets. As a result, they are spending more resources on product development, increasing the market growth of protein labeling.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in the APAC protein labeling market profiled in the report are Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Reagents
5.1.2.1 Enzymes
5.1.2.2 Monoclonal Antibodies
5.1.2.3 Proteins
5.1.2.4 Probes/Tags
5.1.2.5 Other Reagents
5.1.3 Kits
5.1.4 Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Labeling Method
5.2.1 Introduction
5.2.2 In vitro Labeling
5.2.2.1 Enzymatic Labeling
5.2.2.2 Dye-Based Labeling
5.2.2.3 Cotranslational Labeling
5.2.2.4 Site-Specific Labeling
5.2.2.5 Nanoparticle Labeling
5.2.3 In vivo Labeling
5.2.3.1 Photoreactive Labeling
5.2.3.2 Radioactive Labeling
5.2.4 Bioorthogonal Labeling
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Cell-Based Assay
5.3.3 Mass Spectroscopy
5.3.4 Fluorescence Microscopy
5.3.5 Immunological Technique
5.3.6 Protein Microarray
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End user
5.4.1 Introduction
5.4.2 Y-o-Y Growth Analysis, By End user
5.4.2 Market Attractiveness Analysis, By End user
5.4.3 Market Share Analysis, By End user
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Labeling Method
6.1.3.4 By Application
6.1.3.5 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Labeling Method
6.1.4.4 By Application
6.1.4.5 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Labeling Method
6.1.5.4 By Application
6.1.5.5 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 General Electric Company
8.3 Merck KGaA
8.4 Eurogentec S.A.
8.5 PerkinElmer, Inc.
8.6 F. Hoffmann-La Roche AG
8.7 New England Biolabs
8.8 Kaneka Corporation
8.9 Kirkegaard & Perry Laboratories
8.10 Promega Corporation
8.11 LI-COR, Inc.
8.12 SeraCare Life Sciences, Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Apr 2021
